Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation

被引:5
|
作者
Ning, Hui [1 ,2 ]
Liu, Ming [1 ]
Wang, Lina [3 ]
Yang, Yang [1 ]
Song, Nan [1 ]
Xu, Xiaoxiong [1 ]
Ju, Jin [4 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[2] Tianjin Haihe Hosp, Dept Thorac Surg, Tianjin 300350, Peoples R China
[3] Dalian Med Univ, Dept Endodont & Periodont, Coll Stomatol, Dalian 116044, Peoples R China
[4] Weihai Municipal Hosp, Dept Thorac Surg, 70 Heping Rd, Weihai 264200, Peoples R China
基金
中国博士后科学基金;
关键词
Lung cancer; epidermal growth factor receptor ( EGFR) gene; mutation; phenotype; genotype; EGFR MUTATIONS; TYROSINE KINASE; KRAS MUTATIONS; GEFITINIB; ADENOCARCINOMA; CHEMOTHERAPY; SENSITIVITY; INHIBITION; RESISTANCE; PATHWAYS;
D O I
10.21037/jtd.2017.03.13
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Epidermal growth factor receptor (EGFR) gene was the major causative gene of lung cancer and also the specific treatment target. It is necessary to analyze the genotype and phenotype characters of patients. Methods: We investigated 1,034 lung cancer patients in this study. The collected clinicopathological parameters included gender, age at diagnosis, smoking status, pathological TNM stage, tumor morphology and location, visceral pleural invasion as well as histological type. Results: Almost 50% participants had EGFR mutations. L858R in exon 21 was the most common type. Concomitant mutation, 19 del and L858R, were detected in 20 patients. Compared to patients with exon 19 del or L858R mutations solely, they were inclined to have small size adenocarcinomas which occurred in bilateral and invaded the visceral pleura. The tyrosine kinases inhibitors (TKIs)-resistant mutation, insertions in exon 20, was detected in 11 patients. Conclusions: The summarized clinicopathological features will help clinicians to implement the feasible treatment plan.
引用
收藏
页码:796 / 801
页数:6
相关论文
共 50 条
  • [31] Epidermal growth factor receptor expression status in lung cancer correlates with its mutation
    Suzuki, M
    Shigematsu, H
    Hiroshima, K
    Iizasa, T
    Nakatani, Y
    Minna, JD
    Gazdar, AF
    Fujisawa, T
    HUMAN PATHOLOGY, 2005, 36 (10) : 1127 - 1134
  • [32] Impact of smoking on resected lung cancer depends on epidermal growth factor receptor mutation
    Sekihara, Keigo
    Kawase, Akikazu
    Matsubayashi, Yuta
    Tajiri, Tomoya
    Shibata, Motohisa
    Hayakawa, Takamitsu
    Shiiya, Norihiko
    Funai, Kazuhito
    INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 2024, 39 (01):
  • [33] Relationship between Epidermal Growth Factor Receptor Gene Mutations and Clinicopathological Features in Patients with Non-Small Cell Lung Cancer in Western Turkey
    Unal, Olcun Umit
    Oztop, Ilhan
    Calibasi, Gizem
    Baskin, Yasemin
    Koca, Dogan
    Demir, Necla
    Akman, Tulay
    Ellidokuz, Hulya
    Yilmaz, Ahmet Ugur
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3705 - 3709
  • [34] Novel mutations and mutation pattern of epidermal growth factor receptor (EGFR) gene in Chinese patients with primary lung adenocarcinoma
    Mok, T.
    Lui, P.
    Lam, K. C.
    Yim, A.
    Wan, I.
    Lee, S.
    Hsin, M.
    Leung, L.
    To, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment
    Lu, Hong-Yang
    Mao, Wei-Min
    Cheng, Qiao-Yuan
    Chen, Bo
    Cai, Ju-Fen
    Wang, Xiao-Jia
    Wang, Zeng
    Xie, Fa-Jun
    ONCOLOGY LETTERS, 2012, 3 (06) : 1288 - 1292
  • [36] Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients
    Liu, Lanlan
    Xiong, Xianzhi
    CURRENT ONCOLOGY, 2022, 29 (01) : 77 - 93
  • [37] Relationship between epidermal growth factor receptor gene mutation and copy number in Chinese patients with non-small cell lung cancer
    Zhang, Lan-Jun
    Cai, Ling
    Li, Zhe
    Wang, Wu-Ping
    Guo, Kang
    Shao, Jian-Yong
    Wang, Jun-Ye
    Yu, Hui
    Rong, Tie-Hua
    CHINESE JOURNAL OF CANCER, 2012, 31 (10) : 491 - 499
  • [38] Development Of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation In Patients With Breast Cancer History: Case Report
    Fernandez, L.
    Vargas, D. A.
    Sua, L. F.
    Gomez, L. I.
    Rodriguez, L. X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
    Chen, Yu
    Deng, Juan
    Liu, Yu
    Wang, Hao
    Zhao, Sha
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [40] Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing
    Hicks, Karalyn
    Wong, Conroy
    NEW ZEALAND MEDICAL JOURNAL, 2013, 126 (1381) : 49 - 56